
Incyte Announces European Commission Approval Of Opzelura® (Ruxolitinib) Cream For The Treatment Of Non-Segmental Vitiligo With Facial Involvement In Adults And Adolescents
April 20, 2023 at 10:21 AM EDT Opzelura® (ruxolitinib) Cream is…